胸腔内注入尿激酶治疗渗出性胸腔积液疗效观察

• 作 者: 李平 张荇 徐红
• 机 构: 哈尔滨市第四医院,哈尔滨市第四医院,哈尔滨市第六人民医院 150026,150026,150036
• 出 处: 中国初级卫生保健
• 发表日期: 2000年08期
• 关键词: 渗出性胸腔积液 胸膜肥厚 胸膜粘连 胸水吸收 胸穿 尿激酶 胸腔 排液 渗出性胸膜炎 结核性胸膜炎

在渗出性胸腔积液病人的治疗过程中,有两种转归不令人满意。其一是由于胸膜粘连、分隔、包裹、引流不畅,使病程延长,并增加了胸膜肥厚的几率。其二是残遗胸膜肥厚,导致胸廓畸形,不同程度地影响病人的肺功,重者可导致劳动力下降,甚至进展为肺心病。对渗出性胸腔积液过去一直采取常规治疗方法化疗配合胸穿排液。胸水吸收较慢,且很多留有胸膜粘连、肥厚、胸水包裹等后遗症。我们对渗出性胸腔积液病人在治疗过程中,胸穿排液后向胸腔内注入尿激酶,以改

In the treatment of exudative pleural effusion, two outcomes are unsatisfactory. One is due to pleural adhesions, separation, parcels, poor drainage, prolonged course, and increased the risk of pleural thickening. The second is residual pleural hypertrophy, resulting in thoracic deformity, varying degrees of impact on the patient’s lung function, severe cases can lead to decline in labor force, and even progress to pulmonary heart disease. Exudative pleural effusion in the past has been to take conventional treatment of chemotherapy with chest wear drainage. Pleural fluid absorption is slow, and many left pleural adhesions, hypertrophy, pleural effusion and other sequelae. We exudative pleural effusion patients in the course of treatment, after chest wear fluid into the chest to inject urokinase to change